Investment ยท South Africa
South Africa-Founded Healthleap Raises $38 Million to Widen Clinical AI Screening
By: Mohamed Wazen
Healthleap, a clinical AI startup founded in South Africa in 2022, has raised $38 million in combined seed and Series A funding. The company plans to extend its hospital screening platform beyond malnutrition to conditions including congestive heart failure, pressure ulcers and hospital-acquired infections.
Healthleap, a clinical artificial intelligence startup founded in South Africa, has raised US$38 million in combined seed and Series A funding to broaden the range of conditions its platform can detect.
The company was established in 2022 by siblings Josiah and Jemima Meyer. Its platform screens hospital patients for conditions that frequently go undiagnosed. Each morning it reads a patient's full electronic health record, including notes, laboratory results, vital signs, orders and problem lists, and flags clinical risk. It then feeds risk scores into the electronic health record tools clinicians already use, showing care teams which patients need attention first.
Healthleap has so far concentrated on malnutrition. With the new round, it plans to add congestive heart failure, pressure ulcers and a range of hospital-acquired infections. The investors named are Sequoia Capital, First Round Capital and Hummingbird Ventures. Part of the money will also be used to expand the company's engineering, sales, customer success and product teams.
Josiah Meyer, co-founder and chief executive, said millions of patients leave hospitals every week with unresolved health conditions that erode their health and can cost up to ten times more to treat over the long term. He said the aim was to improve care and save lives by identifying such conditions earlier.
Alfred Lin, a partner at Sequoia Capital, said the company was focused on finding patients who are being missed and getting them the care they need. He cited one hospital that saw 39 per cent more malnutrition cases identified and treated, and US$11 million in incremental revenue in a single health system.
Josh Kopelman, co-founder and partner at First Round Capital, said the firm was drawn to a vision in which every hospital uses real-time AI to spot overlooked clinical risk, improve care and unlock reimbursement revenue.